Navigation Links
Improved foam for varicose veins found to be safe in preliminary results from phase II trial
Date:3/16/2008

he small size of the bubbles, the consistency of the foam and the solubility of carbon dioxide.

However, patients with a right-to-left shunt in their hearts a common, usually asymptomatic heart defect in about one-fourth of the population are at increased risk of foam bubbles crossing the shunt and going to the brain or heart without being filtered in the lungs, according to Regan. These patients, the subjects of the study, are continuously monitored by transcranial Doppler ultrasound of the brain before, during and after the procedure. They also undergo magnetic resonance imaging (MRI) of the brain, visual testing, neurological examinations and examinations for changes in cardiac markers in the blood.

During the procedure, a small catheter is placed in the malfunctioning GSV, and the Varisolve foam is injected into the vein. The GSV is compressed in the groin to trap the foam in the leg and additional foam is injected. The patients leg is then put in a compression dressing and stocking, and the patient is able to get up and walk immediately.

In more than 90 percent of the 28 patients studied so far (13 at Wake Forest Baptist) at six research sites across the country, tiny bubbles have been detected in the blood during the procedure. However, no neurological, visual or cardiac changes were observed in the monitoring. The study will continue until a total of 50 patients have been treated and monitored.


'/>"/>

Contact: Robin Brantley
rbrantle@wfubmc.edu
336-716-7334
Wake Forest University Baptist Medical Center
Source:Eurekalert

Page: 1 2

Related biology news :

1. Improved e-jet printing provides higher resolution and more versatility
2. In-vitro fertilization improved with 3-D/4-D-guided embryo transfer and new placement target
3. UCR researchers awarded nearly $1.7M to develop improved cowpea varieties
4. Physician-scientist urges improved drug regulation to ensure heart safety of non-heart drugs
5. Key to out-of-control immune response in lung injury found
6. Natural chemical found in broccoli helps combat skin blistering disease
7. Balzan Foundation announces 2007 winners
8. Keck Foundation funds study of biological interactions with nanomaterials
9. Yu receives research funding from the Wallace H. Coulter Foundation
10. New dinosaur species found in Montana
11. PETA awards $120,000 to Duluth Foundation for advancing non-animal tests
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... DUBLIN , June 25, 2015 ... the addition of the "Next Generation Biometrics Market ... to 2020" report to their offering. ... $24.4 Billion by 2020, at a CAGR of 17.9% ... is the leading application for the market. Safran ...
(Date:6/26/2015)... SPRINGVILLE, Utah , June 26, 2015 ATL ... assemblies and devices with specialties in single use solutions, headquartered ... acquisition of MedConx, Inc. (a California ... , and San Jose, Costa Rica ). ... Costa Rica with ATL Technology,s existing ...
(Date:6/24/2015)... , June 24, 2015 This report provides ... the next six years. It contains an analysis of ... along with their impact from the short, medium, and ... discusses the industry, market, and technology trends that currently, ... need of concerned authorities to efficiently manage the increasing ...
Breaking Biology News(10 mins):Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 2Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 3ATL Technology Announces Acquisition of MedConx, Inc. and Expanded Global Footprint 2Automatic Identification System Market by Class, by Platform, by Application and by Geography - Global Forecasts & Analysis to 2014 - 2020 2
... In January 2012, the United States Department of Agriculture ... lunches more nutritious, which included requiring schools to increase ... fruit or vegetable with their purchased lunch. However, children ... a new study scheduled for publication in The ...
... the western Pacific Ocean may be losing their last ... to a paper published today in the scientific journal ... Researchers from the State University of Papua ... and World Wildlife Fund Indonesia released a report today ...
... The COMBACTE (Combatting Bacterial Resistance in Europe) project, resulting ... IMI, is one of the projects that is part ... It is the result of the initial association between ... run respectively by Marc Bonten of the University of ...
Cached Biology News:Libertarian paternalism and school lunches: Guiding healthier behavior while preserving choices 2New study shows continued decline in the last remaining stronghold for leatherback sea turtles 2COMBACTE: A new step in the fight against resistance to antibiotics 2COMBACTE: A new step in the fight against resistance to antibiotics 3
(Date:7/27/2015)... 27, 2015 Junto Health, a company that ... and develop new technology solutions, today announced the launch ... a leader in health care policy consulting. Working together ... a collaborative innovation process while, at the same time, ... public policy, health care finance and the delivery of ...
(Date:7/24/2015)... , July 24, 2015 Ryan & Maniskas, ... in United States District Court for the Northern District of ... or entities that purchased the common stock of Avalanche Biotechnologies, ... July 31, 2014 and June 15, 2015, inclusive (the "Class ... 8, 2015, move the Court for appointment as a lead ...
(Date:7/24/2015)... Agritech Limited (NASDAQ GS: SEED) ("Origin", or the "Company"), a ... , today announced that the Company will report results for ... before the market opens on Wednesday, August 5th, 2015. ... 2015, at 9:00 a.m. ET / 9:00 p.m. ... in the call, please dial the following numbers approximately 5 ...
(Date:7/23/2015)... ... ... The health and wellness of brain tumor caregivers, often a spouse, parent, sibling ... American Brain Tumor Association presents interactive sessions that address shifting the mindset of caregivers ... Chicago. , “We have understood for a long-time now that caregivers and families ...
Breaking Biology Technology:Junto Health Announces a Unique Partnership with Sachs Policy Group 2Junto Health Announces a Unique Partnership with Sachs Policy Group 3Junto Health Announces a Unique Partnership with Sachs Policy Group 4Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Avalanche Biotechnologies, Inc. 2Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Avalanche Biotechnologies, Inc. 3Origin Agritech Limited to Announce Third Quarter Fiscal 2015 Unaudited Financial Results on August 5th, 2015 2Origin Agritech Limited to Announce Third Quarter Fiscal 2015 Unaudited Financial Results on August 5th, 2015 3Reframing the Caregiver and Patient Mindset: Coping with the ‘New Normal’ 2Reframing the Caregiver and Patient Mindset: Coping with the ‘New Normal’ 3
... -- LEUVEN, Belgium, September 30, 2010 ... ... ... are keyed by longUrl, so we need to grab the first one. for (var r in data.results) ...
... While refining their novel method for making nanoscale ... and Technology (NIST) discovered an unexpected bonusa new ... to that from light-emitting diodes (LEDs). These "nano-LEDs" ... to work serving miniature devices such as nanogenerators ...
... Sept. 29 /PRNewswire-FirstCall/ - Generex Biotechnology Corporation (Nasdaq: ... development, and commercialization of drug delivery systems and technologies, ... Mark Fletcher as Interim President and Chief Executive Officer ... an independent director, to serve as Chairman of the ...
Cached Biology Technology:ThromboGenics Signs Deal With MSD for Long-Term Commercial Supply of Microplasmin 2ThromboGenics Signs Deal With MSD for Long-Term Commercial Supply of Microplasmin 3ThromboGenics Signs Deal With MSD for Long-Term Commercial Supply of Microplasmin 4ThromboGenics Signs Deal With MSD for Long-Term Commercial Supply of Microplasmin 5ThromboGenics Signs Deal With MSD for Long-Term Commercial Supply of Microplasmin 6ThromboGenics Signs Deal With MSD for Long-Term Commercial Supply of Microplasmin 7ThromboGenics Signs Deal With MSD for Long-Term Commercial Supply of Microplasmin 8Growing nanowires horizontally yields new benefit: 'nano-LEDs' 2Generex Biotechnology Appoints Mark Fletcher as Interim President and CEO, and John P. Barratt as Chairman of the Board 2Generex Biotechnology Appoints Mark Fletcher as Interim President and CEO, and John P. Barratt as Chairman of the Board 3
... stands both present the shaker ... and help protect user safety. ... steel, these heavy-duty accessories are ... and minimize the vibration produced ...
... (RNA polymers) are prepared ... of the enzyme, polynucleotide ... and the appropriate, ribonucleoside ... the exception of catalog ...
...
Anti-Tissue Trans-glutaminase (IgA) EIA Sample Size: 10 l...
Biology Products: